HGF has one of the largest and most experienced pharmaceutical patent attorney/lawyer teams in Europe. Many of our attorneys and solicitors have joined from large pharmaceutical companies and bring extensive in-house experience of building, managing enforcing and defending global patent portfolios protecting some of the highest profile medicines in Europe.
Our multidisciplinary team supports clients through all stages of the development and lifespan of a pharmaceutical product. We specialise in providing IP strategy advice, invention capture, drafting and filing patent applications, patent prosecution, infringement analysis, EPO oppositions/appeals, commercialisation across the life cycle and multi-jurisdictional patent litigation. We also have specialist experience of supplementary protection certificates (SPCs), regulatory data exclusivity and IP due diligence. A large part of our pharmaceutical practice involves contentious proceedings in the courts and at the EPO. A number of our experienced patent attorneys specialise in opposition and appeal proceedings before the European Patent Office and are regularly involved with complex and high-value multi-party oppositions. Our team of solicitors, working together with our patent attorneys, are also regularly involved in high-profile pharmaceutical patent disputes i nthe national Courts and across Europe.
In terms of technical expertise, our multidisciplinary team specialises in IP relating to drug compounds, particular forms of drug compounds (salt, solvates and polymorphs), formulations (including advanced drug delivery systems), processes for making drug compounds, methods of treatment and therapeutic uses (including drug repositioning), dosage regimens, combination therapies, drug conjugates (such as antibody drug conjugates and PROTACs) and neutraceuticals.
We’ve built our business by recruiting and developing specialists, not generalists. When it comes to protecting your ideas and business, you want to know you’re working with the best – people who truly understand your sector and the potential of your IP.
HGF’s team has pharmaceuticals professionals from an array of academic and business backgrounds. Our team-based approach ensures our clients benefit from the very best strategic advice from people who understand not only the legal environment but also the practical side of your business.
The possibility of quantum computing was first seriously proposed in the early 1980s and is widely regarded as having enormous potential to deliver a step change in the complexity of …Read article
To celebrate the 50th anniversary of the signing of the European Patent Convention, The European Patent Office (EPO) is running a collaborative art competition for primary schools on the topic …Event details
Before unitary effect can be registered by the EPO, an applicant must first obtain a European patent via the EPO as it does in the current way. In order to …Read article
The technological challenges in the aircraft engine sector are, to put it mildly, considerable at present. Airframers are increasingly reliant on engine manufacturers to produce the bulk of efficiency gains …Read article
In the ninth edition of HGF’s Fashionably IP podcast in the spirit of the new year and new beginnings or at least recycled beginnings, we are going to talk about …Read article
The 5th Annual MarketsandMarkets Next Gen Microbiome and Probiotics Conference will take place in San Diego on the 8th-9th of February. This conference will enable you to learn about microbial …Event details